Amgen's Next-Generation Cholesterol Drug Is Approved, but Pricing Is a Huge Concern
Repatha gets the green light from the Food and Drug Administration, but pharmacy benefit managers and insurers are ready to give PCSK9 inhibitors the red light.
5 Things MannKind Corporation's Management Team Wants You To Know
Management had a lot of information to share with investors when it reported second quarter earnings. Here are 5 key takeaways.